1. Home
  2. >>Scrip
  3. >>Business
  4. >>Deals
  5. >>Deal Watch

Deal Watch

Asia Deal Watch: Kanghua Will Move Into Vaccines By Purchasing Chinese Peer NanoRibo

 
• By Joseph Haas, Dexter Jie Yan, and Jung Won Shin

Plus deals involving Insilico/Qilu, Insilico/Hygtia, AstraZeneca/AbelZeta, Alteogen/Tesaro, Ellipses/Innolake and more.

Deal Watch: Kuva Labs To Go Public Via Merger With Licensing Partner Lisata

 
• By Joseph Haas

Plus deals involving Alfasigma/Innovative Molecules, Genethon/AskBio, XTL/NeuroNOS, ESTEVE/TerSera, Tahoe/Alloy, Bayer/Attralus and more.

Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China

 
• By Joseph Haas, Xu Hu, and Lisa Takagi

Plus deals involving SciNeuro/Novartis, Prazer/J&J, Haisco/AirNexis, Daiichi Sankyo/Genesis, AbbVie/Zelgen, ASK Pharm/Adlai Nortye, Harbour BioMed/Yantai Lannacheng, Hansoh/Hengrui and more.

Deal Watch: Big Pharma Announces AI Modeling Pacts Heading Into JPM

 
• By Joseph Haas

Plus deals involving Amgen/DISCO, Sanofi/Earendil, BI/Variant, Madrigal/Pfizer, Lilly/InduPro, Basilea/Prokaryotics, Synaffix/Sidewinder, Gilead/OncoNano, Pfizer/Cartography, Gilead/Repare and more.

Asia Deal Watch: Qyuns Licenses Bispecific Antibody Candidate To Windward

 
• By Joseph Haas, Lisa Takagi, Jung Won Shin, Anju Ghangurde, Vibha Ravi, Xu Hu, and Dexter Jie Yan

Plus deals involving Samsung/GSK, Galux/Boehringer Ingelheim, Glenmark/Hansoh, Changchun GenSci/Yarrow, Mochida/Duchesnay, OTR/Zealand, Formation/Lynk, Zydus/Formycon and Lee’s/Grupo Ferrer.

Deal Watch: Boehringer Signs On For Rectify’s Chronic Kidney Disease Assets

 
• By Joseph Haas

Plus deals involving GSK/CAMP4, Sagimet/TAPI, Valink/Nona, Vir/Norgine, Genentech/Caris, Pfizer/Adaptive, XOMA/Generation Bio and more.

Asia Deal Watch: Kelun And Crescent Partner And Cross-License Cancer Candidates

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Plus deals involving Simcere/Vigonvita, Formosa/Rxilient, Shionogi/Japan Tobacco, Taiho/NEC/JFCR, Toray/Sanodyne, SK Biopharmaceuticals/WARF, BioCorteX/CD Biopharma, ToolGen/GenEditBio and Actimed/Mankind.

Deal Watch: Akebia Gets Phase II Alopecia Areata Candidate From Cost-Conscious Q32

 
• By Joseph Haas

AstraZeneca quietly acquires Six Peaks, plus deals involving Bayer/Dare, Tempest/Factor, XenoTherapeutics/Repare, DayOne/Mersana and more.

Asia Deal Watch: GSK To Collaborate With LTZ On Myeloid Cell Engagers

 
• By Joseph Haas, Xu Hu, Lisa Takagi, Jung Won Shin, and Sushmita Panda

Plus deals involving Adagene/Third Arc, Celltrion/TRiOar, Celltrion/Kaigene, ImmunoScape/Cue, Laekna/Qilu, Lilly/ABL, Lilly/Sanegene, Sanyou/ZJ Bio-Tech, TransThera/Neurocrine, Qyuns/Roche, Otsuka/4D Molecular, IASO/GC Cell, Chugai/Renalys, Henlius/Forlong and Teijin/Elevara.

Deal Watch: GSK To Tap AN2’s Boron Chemistry Approach In Tuberculosis R&D

 
• By Joseph Haas and Sushmita Panda

Also deals involving Lyell/Innovative Cellular, Lilly/Ailux, Dynavax/Vaxart, AVEO/HiberCell, Incyte/Prelude, AmacaThera/Pacira, Roche/Manifold and Chromatin/Purespring.

Deal Watch: AstraZeneca Remains Busy In AI, Via Deals With Immunai, Turbine And Algen

 
• By Joseph Haas and Lisa Takagi

Plus deals involving Takeda/Innovent, Genentech/Ventus, Sanofi/EVOQ, Novo Nordisk/Sumitomo, Lisata/Catalent, Boehringer Ingelheim/Accent, BI/Molcure, tech transfer agreements and more.

Asia Deal Watch: Chugai Teams With Rani On Oral Version Of Rare Disease Antibody Drug

 
• By Joseph Haas, Jung Won Shin, Lisa Takagi, Xu Hu, and Vibha Ravi

Plus deals involving Astellas/Taysha, Haihe/Taiho, AimedBio/Boehringer Ingelheim, Takeda/Nabla, CytoMed/TC BioPharm, Specialised Therapeutics/CanariaBio, UgeneX/AviadoBio, Lupin, Kissei/Searchlight, Kazia/QIMR and Prism/Servier.

Deal Watch: Clywedog, Barinthus To Merge With Focus On Diabetes, Celiac Disease

 
• By Joseph Haas

Plus deals involving Klotho/Turn, BioLineRx/Hemispherian, Dogwood/Serpin, Harrow/Melt, Gossamer/Respira, Lilly/Prellis, BI/TegMine and more.

Asia Deal Watch: Kyorin Collaborates On Hinge’s Multispecific Antibody For Lupus

 
• By Joseph Haas and Lisa Takagi

Plus deals involving Elix/Tohoku U., Hanmi/Gilead/Hope Health, Heartseed/Novo Nordisk, Novatim/VRise, Qurient/Synaffix, Huons/Therapex, Mochida/Itochu/AND Pharma, Sovargen/Angelini, Starpharma/Genentech, Axcelead/xFOREST and Daiichi Sankyo/Immuto.

Deal Watch: Biogen Acquires Intrathecal Delivery Specialist Alcyone

 
• By Joseph Haas

Plus deals involving Frame Bio/Mercury Bio, Arch Biopartners/Lidpro, Lilly/Remedium, Cadrenal/eXIthera, Vertex/Enlaza and more.

Asia Deal Watch: Aditum Founds Kalexo With Mabwell To Develop Dual-Target SiRNA Asset

 
• By Joseph Haas, Xu Hu, Anju Ghangurde, Vibha Ravi, and Lisa Takagi

Plus deals involving Adagene/Exelixis, Biocytogen/Tubulis, Kwangdong/Ocugen, Dr. Reddy’s/J&J, Zydus/Synthon, Stallergenes/Nuance, Argo/Novartis, XW Pharma/Avadel, Biocytogen/Merck & Co., JCR/Medipal, Novatim/Radiance and more.

Deal Watch: XOMA Buys Troubled Alkermes-Spinout Mural Oncology

 
• By Joseph Haas, Xu Hu, and Lisa Takagi

Plus deals involving Fosun/Accro, Fosun/Sitala, RemeGen/Santen, Firebird/Solasia and more, including tech transfer.

Deal Watch: Lilly Teams With GPCR-Focused Superluminal In Cardiometabolic Disease

 
• By Joseph Haas

Plus deals involving Basilea/Venatorx, CorMedix/Melinta, SERB/Y-mAbs, XOMA/Lava, XOMA/Hillevax, MaxCyte/Adicet/Anocca and Bausch Health/DURECT.

Asia Deal Watch: Lupin Picks Sandoz To Market Lucentis Biosimilar In Parts Of EU And Asia

 
• By Joseph Haas, Sushmita Panda, Xu Hu, Vibha Ravi, and Manas Mishra

Also deals involving Xspray/Handa, Fosun/Expedition, Kaken/Astria, Orchid/Allecra, Sanofi/Visirna, KKR/Healthcare Royalty Partners, Viridian/Kissei, Sandoz/Evotec, Dx&Vx, Dr. Falk/Allianthera, Madrigal/CSPC and Lilly/LTZ.

Deal Watch: Novartis Hopes To Ace Inflammatory Disease With Matchpoint Tie-Up

 
• By Joseph Haas, Lisa Takagi, and Manas Mishra

Plus deals involving Lilly/Gate Bioscience, Concentra/iTeos, Nicox/Kowa, Ajax/Schrodinger, I-Mab/Bridge Health, Otsuka/Cantargia, JCR/Acumen and more.